Analyst Ratings for Rigel Pharmaceuticals (RIGL)

RIGL Rating Summary

RIGL Price Target Summary

* Over Last 12-Mos
  |   Expand Research on RIGL
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $8.50 (+99.5%) * Over Last 12-Mos
Rating Score: 5.8 / 10   Percentile Rank: 60%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/9/2020 JPMorgan Tessa Romero Downgrade Neutral
(Overweight)
N/A
(N/A)
2.74
(4.26)
55.47% Details
11/15/2019 Cantor Fitzgerald
» Updated 2/18/2021
Kristen Kluska New Coverage Overweight
(N/A)
7.00
(5.00)
2.29
(4.26)
86.03% Details
Like RIGL Ratings? Also take a look at LLY, GRFS

RIGL Ratings News